Medication info

Cotonition 10/50 mg

Prescription medicationApproval withdrawn
Ingredient · strength
Amlodipine Besylate›Strength being verifiedLosartan Potassium›Strength being verified
Manufacturer / importer
JW Pharmaceutical Co., Ltd.
Appearance
Pale pink, oblong film-coated tablet
Packaging
30 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 201502709 · Approved 2015.04.30

This product's status changed to Approval withdrawn on 2023.06.02. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension and initial treatment of Stage II hypertension
Who uses it
Adults · Children
Adult dosage
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before treatment with this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using an individual component as follows, switching directly to this medicine may be considered. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should be based on factors such as baseline blood pressure, target blood pressure, and the expected degree of attainment of the treatment goal with the combination product compared with the individual products. Usually, this medicine is administered at 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, administration of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced effective intravascular volume: Administration of this medicine is not recommended in a small number of patients with reduced effective intravascular volume (e.g., patients being treated with high doses of diuretics). (See section 1. Warnings under Precautions for Use.) ○ Patients with hepatic impairment: Administration of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Older adults: In older adults aged 75 years or older, an initial dose of losartan of 25 mg once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.
Children's dosage
○ Pediatric patients: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
JW Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and initial treatment of Stage II hypertension

  • Essential hypertension
  • stage 2 hypertension
View approved original text

This medication is used in patients with essential hypertension who do not achieve sufficient blood pressure control with either amlodipine or losartan monotherapy. It is also used as an initial treatment in stage 2 hypertension patients who require combination therapy to reach target blood pressure. This medication effectively aids in blood pressure control and contributes to reducing the risk of cardiovascular diseases.

Dosage and Administration

Adult dosage

The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before treatment with this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using an individual component as follows, switching directly to this medicine may be considered. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should be based on factors such as baseline blood pressure, target blood pressure, and the expected degree of attainment of the treatment goal with the combination product compared with the individual products. Usually, this medicine is administered at 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, administration of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced effective intravascular volume: Administration of this medicine is not recommended in a small number of patients with reduced effective intravascular volume (e.g., patients being treated with high doses of diuretics). (See section 1. Warnings under Precautions for Use.) ○ Patients with hepatic impairment: Administration of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Older adults: In older adults aged 75 years or older, an initial dose of losartan of 25 mg once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.

Children's dosage

○ Pediatric patients: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, particularly in the second and third trimesters; therefore, it should be discontinued immediately upon confirmation of pregnancy. Pregnant women taking this medication should be cautious due to risks such as impaired fetal kidney function, oligohydramnios, and the potential for congenital abnormalities. Patients with reduced effective blood volume, such as those on diuretics, should stabilize their condition before taking this medication, and it may be better not to administer this medication. Patients with hypersensitivity to this medication or severe hepatic impairment, severe aortic stenosis, or in a state of shock should avoid taking it. Due to the blood pressure-lowering effect, dizziness or drowsiness may occur, so avoid driving or operating hazardous machinery. This medication should be administered cautiously to elderly patients or those with significantly impaired kidney function, as there is a risk of elevated potassium levels when combined with potassium-sparing agents. Regular monitoring of blood pressure, kidney function, and electrolyte levels during treatment is important. In case of overdose, severe hypotension and tachycardia may occur, requiring immediate medical attention. It is safest for children, pregnant women, and nursing mothers not to take this medication. Taking this medication with grapefruit juice may increase blood concentration; therefore, it is advisable to avoid this combination. While on this medication, consult healthcare professionals if taking other antihypertensives, as this may excessively enhance blood pressure-lowering effects.

Side effects

  • Dizziness
  • headache
  • drowsiness
  • cerebral infarction
  • weakness
  • chest discomfort
  • chest pain
  • early satiety
  • peripheral edema
  • pit edema
Show 187 more
  • abdominal discomfort
  • dyspepsia
  • nausea
  • gastroesophageal reflux disease
  • constipation
  • itching
  • hives
  • palpitations
  • flushing
  • orthostatic hypotension
  • facial flushing
  • dyspnea
  • cough
  • conjunctival hyperemia
  • increased urinary frequency
  • fatigue
  • edema
  • vertigo
  • abdominal pain
  • nausea
  • weakness
  • lethargy
  • pain
  • weight gain
  • weight loss
  • hypotension
  • vasculitis
  • hypertonia
  • sensory decrease
  • sensory disturbance
  • peripheral neuropathy
  • syncope
  • taste disturbance
  • tremor
  • erectile dysfunction
  • gynecomastia
  • change in bowel habits
  • dry mouth
  • gastritis
  • gingival hyperplasia
  • pancreatitis
  • vomiting
  • hyperglycemia
  • arthralgia
  • low back pain
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • insomnia
  • mood changes
  • cough
  • rhinitis
  • hair loss
  • increased sweating
  • purpura
  • skin discoloration
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbance
  • increased urination frequency
  • urination disorder
  • nocturia
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • rash
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • sinoatrial block
  • atrioventricular block
  • abdominal discomfort
  • precordial pain
  • diarrhea
  • loose stools
  • constipation
  • skin erythema
  • maculopapular rash
  • heaviness
  • warmth
  • impaired glucose tolerance
  • weakness
  • muscle cramps
  • low back pain
  • leg pain
  • congestion
  • upper respiratory tract infection
  • sinusitis
  • diarrhea
  • sinus disorder
  • pharyngitis
  • myalgia
  • insomnia
  • swelling
  • abdominal pain
  • angioedema
  • skin desquamation
  • hemolysis
  • facial edema
  • fever
  • orthostatic effect
  • syncope
  • angina
  • second-degree atrioventricular block
  • cerebrovascular accident
  • hypotension
  • myocardial infarction
  • atrial fibrillation
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • anorexia
  • toothache
  • flatulence
  • gastritis
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory impairment
  • decreased libido
  • memory impairment
  • migraine
  • neural excitability
  • panic disorder
  • sleep disorder
  • tremor
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • dermatitis
  • dry skin
  • petechial hemorrhage
  • erythema
  • photosensitivity
  • sweating
  • erythema multiforme
  • blurred vision
  • burning eyes
  • pain
  • conjunctivitis
  • dysgeusia
  • tinnitus
  • vision loss
  • urinary tract infection
  • low blood pressure
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • anaphylactic syndrome
  • angioedema
  • vasculitis
  • anaphylactic reaction
  • lethargy
  • anemia
  • thrombocytopenia
  • rhabdomyolysis
  • taste disturbance
  • dry cough
  • hyperkalemia
  • hyponatremia
  • elevated serum creatinine
  • elevated liver enzymes
  • shock symptoms
  • hypotension
  • tachycardia
  • bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. Additionally, it is recommended to store it at room temperature between 1 to 30 degrees Celsius, avoiding extremely hot or cold places.

Appearance and packaging

Appearance

Pale pink, oblong film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.